NOV 24, 2020 6:15 AM PST

Patients on Statins Get the 'Nocebo Effect'

WRITTEN BY: Carmen Leitch

Millions of people around the world take statins to treat high cholesterol. The drugs are estimated to reduce the risk of heart attack by 25 to 35 percent. But many of these patients complain about the side effects of the drugs.

Image credit: Pxhere

Researchers have now found that placebos cause side effects that are similar to those caused by statins. The research suggested that about 20 percent of people who stop taking statins because of the side effects they experience may actually be experiencing the nocebo effect. The nocebo effect describes a phenomenon in which a person experiences side effects because of their negative perception of a drug rather than a true pharmacological effect.

The study, which was reported in the New England Journal of Medicine, was a trial that involved 60 patients. The researchers determined that 90 percent of the symptoms that patients have while taking statins were also happening when they took placebo pills. Doctors may be able to counsel patients about their perceptions and reduce the negative effects they feel.

"Statins play a vital role in lowering cholesterol levels and decreasing the risk of serious vessel-related diseases. However, some patients are stopping their treatment as a result of perceived side effects," said joint first study author Frances Wood of Imperial college of London's National Heart and Lung Institute. "Our study can help doctors manage patients' expectations of statins and to explain more clearly to patients the possibility that some side effects they experience may be caused by the nocebo effect and provide further support if needed."

The 60 study participants, aged 39 to 70, were already taking statins but between 2016 and 2019 had ceased the treatment because of the side effects they experienced. In this work, they were given four bottles of a statin and four bottles of a placebo to take over one year. The tablets appeared identical, the participants did not know which was which, and the bottles were taken in a random order. They took the pills bottle by bottle and rated their side effects on a scale of 0 to 100.

The researchers found that 90 percent of the side effects patients reported from statins were also present when they took placebos. During months when they took placebos, the mean side effect intensity was 15.4 and during the months while they were on statins, it was 16.3. Some people also briefly halted their drug intake due to side effects, and a few left the trial early. The researchers found that of the 71 total stoppages during the trial, 31 happened while people were taking placebos and 40 occurred while people were taking statins.

Additional work will be needed to determine whether the remaining ten percent of side effects are due to statins or the nocebo effect. Since the trial ended, thirty patients had successfully started their statin therapy again.

"The beauty of this study is that it's personalized. For the first time, patients were able to see for themselves that statins did not cause their side effects but the physical act of taking a pill did. These results undeniably show that statins are not responsible for many of the side effects attributed to them. Decades of evidence have proven that statins save lives and they should be the first port of call for individuals at high risk of heart attack and stroke," said study author Professor Sir Nilesh Samani, Medical Director at the British Heart Foundation.

"This study empowered many of the participants to go back onto statins, which will undoubtedly lower their risk of having a life-threatening heart attack or stroke. We now hope that these findings continue to encourage more people to consider statins with an open mind, and help healthcare professionals to have evidence-based conversations with their patients to ensure they receive the treatment that's right for them."

Sources: AAAS/Eurekalert! via Imperial College of London, New England Journal of Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
SEP 23, 2020
Cannabis Sciences
Hemp Seeds May Reduce Heart Disease Risk
SEP 23, 2020
Hemp Seeds May Reduce Heart Disease Risk
Heart disease is the leading cause of death around the world. And it seems that many methods to avoid it involve lifesty ...
NOV 03, 2020
Cardiology
A New Peptide Could Help Repair and Protect the Heart During Ischemia Reperfusion Injury
NOV 03, 2020
A New Peptide Could Help Repair and Protect the Heart During Ischemia Reperfusion Injury
Cardiovascular disease is one of the most common causes of death in the world. Although we have many treatments against ...
NOV 17, 2020
Cardiology
Validating Blood Pressure Functionality in a New Smartwatch
NOV 17, 2020
Validating Blood Pressure Functionality in a New Smartwatch
One of the most exciting advancements in our time is wearable technology. While most see it as a cool piece of tech on y ...
NOV 26, 2020
Cardiology
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
NOV 26, 2020
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
Cardiovascular disease and diabetes are often associated with each other, as many issues caused by diabetes promote hear ...
DEC 29, 2020
Cardiology
Does Physical Activity Help Reduce the Risk of Aneurysms?
DEC 29, 2020
Does Physical Activity Help Reduce the Risk of Aneurysms?
An active lifestyle is a proven way to prevent many types of cardiovascular diseases. The increased blood flow can preve ...
Loading Comments...